Novavax (NVAX) Interest & Investment Income (2010 - 2021)
Novavax's (NVAX) quarterly Interest & Investment Income came in at $303000.0 in Q4 2021, up 113.38% year-on-year from $142000.0 in Q4 2020, and down 8.18% quarter-over-quarter from $330000.0 in Q3 2021.
Novavax (NVAX) Interest & Investment Income (2010 - 2021) Analysis & Trends
Novavax's Interest & Investment Income history runs 12 years deep, the most recent figure standing at $303000.0 for Q4 2021.
- On a quarterly basis, Interest & Investment Income rose 113.38% year-over-year to $303000.0 in Q4 2021; TTM through Dec 2021 was $1.4 million, a 34.38% increase from a year earlier, with the FY2021 full-year figure at $1.4 million, up 34.52% from the prior year.
- Interest & Investment Income declined to $303000.0 in Q4 2021 per NVAX's latest filing, from $330000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $807000.0 in Q2 2018 and bottomed at $140000.0 in Q3 2020.
- The 5-year median for Interest & Investment Income is $419000.0 (2017), against an average of $425550.0.
- Across the five-year window, Interest & Investment Income tumbled 68.78% in 2017 and jumped 135.71% in 2021, its largest moves.
- Year by year, Interest & Investment Income stood at $418000.0 in 2017, then soared by 39.71% to $584000.0 in 2018, then plunged by 52.74% to $276000.0 in 2019, then plunged by 48.55% to $142000.0 in 2020, then soared by 113.38% to $303000.0 in 2021.
- Per Business Quant, the three latest NVAX Interest & Investment Income figures stand at $303000.0 (Q4 2021), $330000.0 (Q3 2021), and $369000.0 (Q2 2021).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Novavax | 1.23 Bn | 435.05 Mn | 108.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 303,000.00 |
| Sep 30, 2021 | 330,000.00 |
| Jun 30, 2021 | 369,000.00 |
| Mar 31, 2021 | 362,000.00 |
| Dec 31, 2020 | 142,000.00 |
| Sep 30, 2020 | 140,000.00 |
| Jun 30, 2020 | 297,000.00 |
| Mar 31, 2020 | 436,000.00 |
| Dec 31, 2019 | 276,000.00 |
| Sep 30, 2019 | 342,000.00 |
| Jun 30, 2019 | 474,000.00 |
| Mar 31, 2019 | 420,000.00 |
| Dec 31, 2018 | 584,000.00 |
| Sep 30, 2018 | 752,000.00 |
| Jun 30, 2018 | 807,000.00 |
| Mar 31, 2018 | 531,000.00 |
| Dec 31, 2017 | 418,000.00 |
| Sep 30, 2017 | 531,000.00 |
| Jun 30, 2017 | 523,000.00 |
| Mar 31, 2017 | 474,000.00 |